Mubadala Capital has sold its minority stake in Arcadia Consumer Healthcare to funds managed by Bansk Group, marking the end of a four-year partnership that tripled the platform's revenue and...
Merck & Co. has terminated acquisition discussions with Revolution Medicines after failing to agree on price for a potential $28-32 billion deal, triggering a 20% drop in Revolution's shares and...
BioCryst Pharmaceuticals Inc. (NasdaqGS: BCRX) completed its acquisition of Astria Therapeutics Inc. (NasdaqGM: ATXS) from a group of shareholders on January 23, 2026, in a deal valued at $700...
The Clorox Company has agreed to acquire GOJO Industries, the Ohio-based manufacturer of Purell hand sanitizer and skin health products, in an all-cash transaction valued at $2.25 billion. The deal...
Former executives of a health technology company that went public through a SPAC merger have agreed to a $10 million settlement to resolve investor lawsuits alleging they triggered a bankruptcy...
GSK agreed to acquire Rapt Therapeutics for $58 per share in cash, valuing the clinical-stage biotech at $2.2 billion in equity and requiring a net cash commitment of $1.9 billion after accounting...
AstraZeneca's chief financial officer emphasized disciplined **M&A strategy** in pharmaceuticals, targeting bolt-on acquisitions to bolster its oncology and rare disease portfolios while eyeing...
Sanofi is revising its takeover offer for Ocular Therapeutix after the U.S. biotech rejected the French drugmaker's initial $16 per share proposal, according to recent filings and market reports. ...
```html Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', 'Helvetica Neue', sans-serif; line-height:...
Johnson & Johnson (NYSE: JNJ) secured a partial victory from Delaware's Supreme Court, overturning a key element of a $1 billion damages award tied to its 2019 $3.4 billion acquisition of...
